{"Abbreviation":"","Aliases":["Naloxiphan","Lorfan","Levallorphane","Levalorfano","17-Allylmorphinan-3-ol","Levallofano","Levallorphanum","N-Allyl-3-hydroxymorphinan","(-)-3-Hydroxy-N-allylmorphinan","Levo-3-hydroxy-N-allyl morphinan"],"Biological Half-Life":"1 hour","CAS":"152-02-3","ChEBI":"CHEBI:6431","ChEMBL":"CHEMBL1254682","ChemicalClasses":["morphinan"],"Chirality":"absolute","Classes":["Opioid","Opioid antagonist"],"Color/Form":"CRYSTALS FROM DILUTE ETHANOL","Dosing Info":[],"Drug Indication":"For the complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids.","Drug Warnings":"IT IS CONTRAINDICATED IN MILD RESP DEPRESSION \u0026 IN NARCOTIC ADDICTS, SINCE IT MAY INDUCE WITHDRAWAL SYMPTOMS. /TARTRATE/","DrugClasses":["opioid"],"EINECS":"205-799-1","EliminationHalfLife":"","European Community (EC) Number":"205-799-1","FullSalts":["Levallorphan tartrate"],"HMDB ID":"HMDB0014647","HeavyAtomCount":21,"Human Drugs":"Human drug -\u003e Discontinued","IUPACName":"(1R,9R,10R)-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol","InChI":"InChI=1S/C19H25NO/c1-2-10-20-11-9-19-8-4-3-5-16(19)18(20)12-14-6-7-15(21)13-17(14)19/h2,6-7,13,16,18,21H,1,3-5,8-12H2/t16-,18+,19+/m0/s1","InChIKey":"OZYUPQUCAUTOBP-QXAKKESOSA-N","MeSH Pharmacological Classification":"Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)","Melting Point":"180-182 °C","MolecularFormula":"C\u003csub\u003e19\u003c/sub\u003eH\u003csub\u003e25\u003c/sub\u003eNO","MolecularWeight":"283.4 g/mol","Opticalactivity":"UNSPECIFIED","Pharmacodynamics":"Levallorphan, an opioid antagonist similar to naloxone, is used to treat drug overdoses. Levallorphan differs from naloxone in that it also possesses some agonist properties. It is an analogue of levelorphanol that counteracts the actions of narcotic analgesics such as morphine. It is used especially in the treatment of respiratory depression due to narcotic overdoses. Levallorphan prevents or reverses the effects of opioids including respiratory depression, sedation and hypotension. Also, it can reverse the psychotomimetic and dysphoric effects of agonist-antagonists such as pentazocine.","Physical Description":"Solid","PrevSalts":["tartrate"],"PubChemId":5359371,"Record Description":["Levallorphan is a morphinane alkaloid.","An opioid antagonist with properties similar to those of naloxone; in addition it also possesses some agonist properties. It should be used cautiously; levallorphan reverses severe opioid-induced respiratory depression but may exacerbate respiratory depression such as that induced by alcohol or other non-opioid central depressants. (From Martindale, The Extra Pharmacopoeia, 30th ed, p683)","Levallorphan has been reported in Papaver somniferum and Euglena gracilis with data available.","LEVALLORPHAN is a small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982.","An opioid antagonist with properties similar to those of NALOXONE; in addition it also possesses some agonist properties. It should be used cautiously; levallorphan reverses severe opioid-induced respiratory depression but may exacerbate respiratory depression such as that induced by alcohol or other non-opioid central depressants. (From Martindale, The Extra Pharmacopoeia, 30th ed, p683)","Levallorphan is a morphinane alkaloid."],"References":[{"Name":"Wikipedia","Urls":[{"Link":"https://en.wikipedia.org/wiki/Levallorphan","Name":"Levallorphan","Sub":false}]},{"Name":"Wikidata","Urls":[{"Link":"https://www.wikidata.org/wiki/Q6534827","Name":"Levallorphan","Sub":false}]},{"Name":"DrugBank","Urls":[{"Link":"https://go.drugbank.com/drugs/DB00504","Name":"Levallorphan","Sub":false}]},{"Name":"PubChem","Urls":[{"Link":"https://pubchem.ncbi.nlm.nih.gov/compound/5359371","Name":"Levallorphan","Sub":false}]},{"Name":"ChEMBL","Urls":[{"Link":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1254682","Name":"Levallorphan","Sub":false}]},{"Name":"ChEBI","Urls":[{"Link":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:6431","Name":"Levallorphan","Sub":false}]},{"Name":"Common Chemistry","Urls":[{"Link":"https://commonchemistry.cas.org/detail?cas_rn=152-02-3","Name":"Levallorphan","Sub":false}]},{"Name":"HMDB","Urls":[{"Link":"https://hmdb.ca/metabolites/HMDB0014647","Name":"Levallorphan","Sub":false}]},{"Name":"KEGG","Urls":[{"Link":"https://www.kegg.jp/entry/C07069","Name":"Levallorphan","Sub":false}]},{"Name":"UNII","Urls":[{"Link":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/353613BU4U","Name":"Levallorphan","Sub":false}]},{"Name":"EPA DSSTox","Urls":[{"Link":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID9023205","Name":"Levallorphan","Sub":false}]}],"SMILES":"C=CCN1CC[C@]23CCCC[C@H]2[C@H]1CC4=C3C=C(C=C4)O","Salts":["tartrate"],"SaltsAcidCount":[1],"SaltsAmineCount":[1],"SaltsUNII":["U0VSF7HTN0"],"Scheduling":[],"Solubility":"WHITE OR PRACTICALLY WHITE CRYSTALLINE POWDER; 1 G SOL IN ABOUT 20 ML WATER; PRACTICALLY INSOL IN ETHER; INSOL IN CHLOROFORM; 1 G SOL IN ABOUT 60 ML ALCOHOL /TARTRATE/","Stability/Shelf Life":"SENSITIVE TO LIGHT /TARTRATE/","StoreUNII":["353613BU4U"],"StructureBase64":"<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" height="88.227mm" version="1.2" viewBox="0 0 101.201 88.227" width="101.201mm">
      
    <desc>Generated by the Chemistry Development Kit (http://github.com/cdk)</desc>
      
    <g fill="#000000" stroke="#000000" stroke-linecap="round" stroke-linejoin="round" stroke-width=".7">
            
        <rect fill="#FFFFFF" height="89.0" stroke="none" width="102.0" x=".0" y=".0"/>
            
        <g class="mol" id="mol1">
                  
            <g class="bond" id="mol1bnd1">
                        
                <line x1="94.21" x2="100.182" y1="72.24" y2="86.252"/>
                        
                <line x1="92.519" x2="97.939" y1="74.491" y2="87.208"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd2" x1="94.21" x2="79.09" y1="72.24" y2="70.406"/>
                  
            <line class="bond" id="mol1bnd3" x1="79.09" x2="74.711" y1="70.406" y2="60.131"/>
                  
            <line class="bond" id="mol1bnd4" x1="73.169" x2="73.321" y1="52.544" y2="41.162"/>
                  
            <line class="bond" id="mol1bnd5" x1="73.321" x2="46.716" y1="41.162" y2="41.162"/>
                  
            <path class="bond" d="M33.341 48.475l.35 .606l18.88 -8.269h-5.248h-3.505z" id="mol1bnd6" stroke="none"/>
                  
            <line class="bond" id="mol1bnd7" x1="33.516" x2="20.315" y1="48.778" y2="56.394"/>
                  
            <line class="bond" id="mol1bnd8" x1="20.315" x2="20.315" y1="56.394" y2="71.625"/>
                  
            <line class="bond" id="mol1bnd9" x1="20.315" x2="33.516" y1="71.625" y2="79.241"/>
                  
            <line class="bond" id="mol1bnd10" x1="33.516" x2="46.716" y1="79.241" y2="71.625"/>
                  
            <line class="bond" id="mol1bnd11" x1="46.716" x2="46.716" y1="71.625" y2="56.394"/>
                  
            <line class="bond" id="mol1bnd12" x1="33.516" x2="46.716" y1="48.778" y2="56.394"/>
                  
            <line class="bond" id="mol1bnd13" x1="46.716" x2="59.917" y1="56.394" y2="48.778"/>
                  
            <line class="bond" id="mol1bnd14" x1="69.964" x2="59.917" y1="54.574" y2="48.778"/>
                  
            <path class="bond" d="M59.917 49.128c-.175 -.0 -.35 -.175 -.35 -.35v-6.649v-.0h.7v.0v6.654c.0 .175 -.175 .35 -.35 .35zM59.567 40.201v-6.655c.0 .0 .175 -.35 .35 -.35c.175 .0 .35 .175 .35 .35v6.651v-.0h-.7z" id="mol1bnd15" stroke="none"/>
                  
            <line class="bond" id="mol1bnd16" x1="59.917" x2="46.716" y1="33.546" y2="25.931"/>
                  
            <g class="bond" id="mol1bnd17">
                        
                <line x1="33.516" x2="46.716" y1="33.546" y2="25.931"/>
                        
                <line x1="33.516" x2="44.278" y1="30.731" y2="24.522"/>
                      
            </g>
                  
            <g class="bond" id="mol1bnd18">
                        
                <line x1="33.166" x2="33.866" y1="48.778" y2="48.778"/>
                        
                <line x1="32.874" x2="34.157" y1="46.239" y2="46.239"/>
                        
                <line x1="32.582" x2="34.449" y1="43.701" y2="43.701"/>
                        
                <line x1="32.291" x2="34.741" y1="41.162" y2="41.162"/>
                        
                <line x1="31.999" x2="35.033" y1="38.624" y2="38.624"/>
                        
                <line x1="31.707" x2="35.324" y1="36.085" y2="36.085"/>
                        
                <line x1="31.415" x2="35.616" y1="33.546" y2="33.546"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd19" x1="33.516" x2="20.315" y1="33.546" y2="25.931"/>
                  
            <g class="bond" id="mol1bnd20">
                        
                <line x1="20.315" x2="20.315" y1="10.699" y2="25.931"/>
                        
                <line x1="22.753" x2="22.753" y1="12.107" y2="24.522"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd21" x1="20.315" x2="33.516" y1="10.699" y2="3.083"/>
                  
            <g class="bond" id="mol1bnd22">
                        
                <line x1="46.716" x2="33.516" y1="10.699" y2="3.083"/>
                        
                <line x1="44.278" x2="33.516" y1="12.107" y2="5.898"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd23" x1="46.716" x2="46.716" y1="25.931" y2="10.699"/>
                  
            <line class="bond" id="mol1bnd24" x1="20.315" x2="10.401" y1="10.699" y2="4.973"/>
                  
            <path class="bond" d="M46.366 56.393h.7l1.314 -11.381h-1.658h-1.658z" id="mol1bnd25" stroke="none"/>
                  
            <path class="bond" d="M59.725 49.424c-.056 -.0 -.111 -.013 -.158 -.04c-.152 -.087 -.216 -.327 -.128 -.478l.35 -.606c.067 -.067 .222 -.158 .359 -.158c.043 .0 .083 .009 .119 .03c.152 .087 .216 .326 .128 .478l-.35 .606c-.06 .105 -.193 .168 -.32 .168zM57.694 48.475c-.057 -.0 -.112 -.013 -.159 -.04c-.151 -.087 -.215 -.326 -.128 -.478l.545 -.943c.067 -.067 .222 -.157 .359 -.157c.043 -.0 .083 .008 .119 .029c.152 .087 .216 .327 .128 .478l-.545 .943c-.06 .105 -.193 .168 -.319 .168zM55.662 47.526c-.057 -.0 -.112 -.013 -.159 -.04c-.151 -.087 -.215 -.326 -.128 -.478l.74 -1.28c.066 -.067 .222 -.157 .359 -.157c.042 -.0 .083 .009 .119 .029c.151 .088 .215 .327 .128 .478l-.739 1.28c-.061 .105 -.194 .168 -.32 .168zM53.63 46.577c-.056 .0 -.111 -.013 -.158 -.04c-.152 -.087 -.216 -.326 -.128 -.478l.933 -1.616c.067 -.067 .223 -.158 .36 -.158c.042 .0 .083 .009 .119 .03c.151 .087 .215 .326 .128 .478l-.934 1.616c-.061 .105 -.193 .168 -.32 .168zM51.598 45.628c-.056 .0 -.111 -.012 -.158 -.039c-.152 -.088 -.216 -.327 -.128 -.479l1.128 -1.953c.067 -.067 .222 -.157 .359 -.157c.043 -.0 .084 .008 .119 .029c.152 .087 .216 .327 .128 .478l-1.128 1.954c-.06 .104 -.193 .167 -.32 .167zM47.535 43.73c-.057 .0 -.112 -.012 -.159 -.039c-.151 -.088 -.215 -.327 -.128 -.478l.582 -1.008v.0h.812v-.0l-.787 1.363c-.061 .104 -.194 .167 -.32 .167zM49.567 44.679c-.057 .0 -.112 -.012 -.159 -.039c-.151 -.088 -.215 -.327 -.128 -.479l1.14 -1.973v.0h.807v-.0c-.005 .013 -.011 .026 -.018 .038l-1.323 2.291c-.06 .104 -.193 .167 -.319 .167zM45.503 42.782c-.056 -.0 -.111 -.013 -.158 -.04c-.152 -.088 -.216 -.327 -.128 -.478l.579 -1.003l.017 .089l.076 .583h.136l.167 .042v.0l-.369 .639c-.061 .105 -.193 .168 -.32 .168zM46.356 40.292l.572 -.992c.067 -.067 .223 -.157 .36 -.157c.042 -.0 .083 .008 .119 .029c.151 .087 .215 .326 .128 .478l-.365 .632v-.0h-.808v.005z" id="mol1bnd26" stroke="none"/>
                  
            <path class="atom" d="M75.058 58.843h-.72l-2.619 -4.066h-.03q.012 .239 .03 .596q.024 .357 .024 .732v2.738h-.566v-4.899h.714l2.608 4.054h.03q-.006 -.107 -.018 -.327q-.012 -.221 -.024 -.477q-.006 -.262 -.006 -.482v-2.768h.577v4.899z" fill="#3050F8" id="mol1atm4" stroke="none"/>
                  
            <g class="atom" id="mol1atm21">
                        
                <path d="M9.385 3.078q-.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.5 .315 -1.245 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.244 -.572 -.244 -1.334q.0 -.75 .244 -1.309q.25 -.566 .756 -.881q.506 -.316 1.274 -.316q.733 .0 1.233 .316q.5 .309 .756 .875q.256 .565 .256 1.327zM5.521 3.078q.0 .923 .387 1.459q.393 .53 1.22 .53q.84 -.0 1.221 -.53q.387 -.536 .387 -1.459q-.0 -.929 -.387 -1.452q-.381 -.524 -1.209 -.524q-.833 -.0 -1.226 .524q-.393 .523 -.393 1.452z" fill="#FF0D0D" stroke="none"/>
                        
                <path d="M4.305 5.531h-.62v-2.286h-2.512v2.286h-.613v-4.9h.613v2.072h2.512v-2.072h.62v4.9z" fill="#FF0D0D" stroke="none"/>
                      
            </g>
                  
            <path class="atom" d="M48.596 43.612h-.619v-2.286h-2.512v2.286h-.614v-4.9h.614v2.072h2.512v-2.072h.619v4.9z" id="mol1atm22" stroke="none"/>
                  
            <path class="atom" d="M44.379 41.172h-.619v-2.286h-2.512v2.286h-.614v-4.899h.614v2.071h2.512v-2.071h.619v4.899z" id="mol1atm23" stroke="none"/>
                
            <line class="hi" id="mol1bnd3" stroke="#3050F8" x1="74.711" x2="76.9005" y1="60.131" y2="65.2685"/>
            <line class="hi" id="mol1bnd4" stroke="#3050F8" x1="73.169" x2="73.245" y1="52.544" y2="46.852999999999994"/>
            <line class="hi" id="mol1bnd14" stroke="#3050F8" x1="69.964" x2="64.9405" y1="54.574" y2="51.676"/>
            <line class="hi" id="mol1bnd24" stroke="#FF0D0D" x1="10.401" x2="15.358" y1="4.973" y2="7.836"/>
            <line class="hi" id="mol1bnd24" stroke="#FF0D0D" x1="10.401" x2="15.358" y1="4.973" y2="7.836"/>
        </g>
          
    </g>
    
</svg>
","Therapeutic Uses":"Narcotic Antagonists","Title":"Levallorphan","UNII":"353613BU4U","Wikidata":"Q6534827","Wikipedia":"Levallorphan","XLogP":3.5}